PMID 24499291
KFF recently reported that GLP-1 drug discontinuation was more common in those over 65, although this could change if Medicare begins to cover these medications for those without diabetes
But with Ozempic, Wegovy, Mounjaro, and Zepbound all making headlines, patients are understandably confused which one actually works best, and which one is right for your body
Fr du forpligter dig, kan du teste svartider via chat eller mail og se, om hjlpen er bde hurtig og prcis
While these treatments can deliver impressive results when used properly, they often come with several Common GLP-1 Weight-loss Side Effects that you should be aware of
Hepatic Steatosis : Recently, a sub-study of the phase 3 clinical trial SURPASS-3 showed that, among patients receiving metformin and/or SGLT2 inhibitors, the addition of tirzepatide (10 or 15 mg) as compared to insulin degludec was able to significantly reduce hepatic fat content (evaluated by magnetic resonance) after 52 weeks of treatment
